table of content
1 Study Coverage
1.1 PRRS Vaccines Product Introduction
1.2 Global PRRS Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global PRRS Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global PRRS Vaccines Sales in Volume for the Year 2017-2028
1.3 United States PRRS Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States PRRS Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States PRRS Vaccines Sales in Volume for the Year 2017-2028
1.4 PRRS Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States PRRS Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of PRRS Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 PRRS Vaccines Market Dynamics
1.5.1 PRRS Vaccines Industry Trends
1.5.2 PRRS Vaccines Market Drivers
1.5.3 PRRS Vaccines Market Challenges
1.5.4 PRRS Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 PRRS Vaccines Market Segment by Type
2.1.1 Live Vaccines
2.1.2 Killed Vaccines
2.2 Global PRRS Vaccines Market Size by Type
2.2.1 Global PRRS Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global PRRS Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global PRRS Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States PRRS Vaccines Market Size by Type
2.3.1 United States PRRS Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States PRRS Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States PRRS Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 PRRS Vaccines Market Segment by Application
3.1.1 Government Tender
3.1.2 Market Sales
3.2 Global PRRS Vaccines Market Size by Application
3.2.1 Global PRRS Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global PRRS Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global PRRS Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States PRRS Vaccines Market Size by Application
3.3.1 United States PRRS Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States PRRS Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States PRRS Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global PRRS Vaccines Competitor Landscape by Company
4.1 Global PRRS Vaccines Market Size by Company
4.1.1 Top Global PRRS Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global PRRS Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global PRRS Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global PRRS Vaccines Price by Manufacturer (2017-2022)
4.2 Global PRRS Vaccines Concentration Ratio (CR)
4.2.1 PRRS Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of PRRS Vaccines in 2021
4.2.3 Global PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global PRRS Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global PRRS Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers PRRS Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into PRRS Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States PRRS Vaccines Market Size by Company
4.5.1 Top PRRS Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States PRRS Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States PRRS Vaccines Sales by Players (2020, 2021 & 2022)
5 Global PRRS Vaccines Market Size by Region
5.1 Global PRRS Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global PRRS Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global PRRS Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global PRRS Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global PRRS Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global PRRS Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global PRRS Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America PRRS Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America PRRS Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific PRRS Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific PRRS Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe PRRS Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe PRRS Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America PRRS Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America PRRS Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa PRRS Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa PRRS Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 CAHIC
7.1.1 CAHIC Corporation Information
7.1.2 CAHIC Description and Business Overview
7.1.3 CAHIC PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 CAHIC PRRS Vaccines Products Offered
7.1.5 CAHIC Recent Development
7.2 Merial
7.2.1 Merial Corporation Information
7.2.2 Merial Description and Business Overview
7.2.3 Merial PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merial PRRS Vaccines Products Offered
7.2.5 Merial Recent Development
7.3 MSD Animal Health
7.3.1 MSD Animal Health Corporation Information
7.3.2 MSD Animal Health Description and Business Overview
7.3.3 MSD Animal Health PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 MSD Animal Health PRRS Vaccines Products Offered
7.3.5 MSD Animal Health Recent Development
7.4 Chopper Biology
7.4.1 Chopper Biology Corporation Information
7.4.2 Chopper Biology Description and Business Overview
7.4.3 Chopper Biology PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Chopper Biology PRRS Vaccines Products Offered
7.4.5 Chopper Biology Recent Development
7.5 Ceva
7.5.1 Ceva Corporation Information
7.5.2 Ceva Description and Business Overview
7.5.3 Ceva PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Ceva PRRS Vaccines Products Offered
7.5.5 Ceva Recent Development
7.6 ChengDu Tecbond
7.6.1 ChengDu Tecbond Corporation Information
7.6.2 ChengDu Tecbond Description and Business Overview
7.6.3 ChengDu Tecbond PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 ChengDu Tecbond PRRS Vaccines Products Offered
7.6.5 ChengDu Tecbond Recent Development
7.7 Veterinary
7.7.1 Veterinary Corporation Information
7.7.2 Veterinary Description and Business Overview
7.7.3 Veterinary PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Veterinary PRRS Vaccines Products Offered
7.7.5 Veterinary Recent Development
7.8 Ringpu Biology
7.8.1 Ringpu Biology Corporation Information
7.8.2 Ringpu Biology Description and Business Overview
7.8.3 Ringpu Biology PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Ringpu Biology PRRS Vaccines Products Offered
7.8.5 Ringpu Biology Recent Development
7.9 Qilu Animal
7.9.1 Qilu Animal Corporation Information
7.9.2 Qilu Animal Description and Business Overview
7.9.3 Qilu Animal PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Qilu Animal PRRS Vaccines Products Offered
7.9.5 Qilu Animal Recent Development
7.10 DHN
7.10.1 DHN Corporation Information
7.10.2 DHN Description and Business Overview
7.10.3 DHN PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 DHN PRRS Vaccines Products Offered
7.10.5 DHN Recent Development
7.11 CAVAC
7.11.1 CAVAC Corporation Information
7.11.2 CAVAC Description and Business Overview
7.11.3 CAVAC PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 CAVAC PRRS Vaccines Products Offered
7.11.5 CAVAC Recent Development
7.12 Komipharm
7.12.1 Komipharm Corporation Information
7.12.2 Komipharm Description and Business Overview
7.12.3 Komipharm PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Komipharm Products Offered
7.12.5 Komipharm Recent Development
7.13 Agrovet
7.13.1 Agrovet Corporation Information
7.13.2 Agrovet Description and Business Overview
7.13.3 Agrovet PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Agrovet Products Offered
7.13.5 Agrovet Recent Development
7.14 Bioveta
7.14.1 Bioveta Corporation Information
7.14.2 Bioveta Description and Business Overview
7.14.3 Bioveta PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Bioveta Products Offered
7.14.5 Bioveta Recent Development
7.15 Jinyu Bio-Technology
7.15.1 Jinyu Bio-Technology Corporation Information
7.15.2 Jinyu Bio-Technology Description and Business Overview
7.15.3 Jinyu Bio-Technology PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Jinyu Bio-Technology Products Offered
7.15.5 Jinyu Bio-Technology Recent Development
7.16 Institutul Pasteur
7.16.1 Institutul Pasteur Corporation Information
7.16.2 Institutul Pasteur Description and Business Overview
7.16.3 Institutul Pasteur PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Institutul Pasteur Products Offered
7.16.5 Institutul Pasteur Recent Development
7.17 MVP
7.17.1 MVP Corporation Information
7.17.2 MVP Description and Business Overview
7.17.3 MVP PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.17.4 MVP Products Offered
7.17.5 MVP Recent Development
7.18 Tecon
7.18.1 Tecon Corporation Information
7.18.2 Tecon Description and Business Overview
7.18.3 Tecon PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Tecon Products Offered
7.18.5 Tecon Recent Development
7.19 Zoetis
7.19.1 Zoetis Corporation Information
7.19.2 Zoetis Description and Business Overview
7.19.3 Zoetis PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Zoetis Products Offered
7.19.5 Zoetis Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 PRRS Vaccines Industry Chain Analysis
8.2 PRRS Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 PRRS Vaccines Distributors
8.3 PRRS Vaccines Production Mode & Process
8.4 PRRS Vaccines Sales and Marketing
8.4.1 PRRS Vaccines Sales Channels
8.4.2 PRRS Vaccines Distributors
8.5 PRRS Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
